These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8447444)

  • 1. Metabolic clearance of vasopressin and an analogue resistant to vasopressinase in human pregnancy.
    Davison JM; Sheills EA; Philips PR; Barron WM; Lindheimer MD
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F348-53. PubMed ID: 8447444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy.
    Davison JM; Sheills EA; Barron WM; Robinson AG; Lindheimer MD
    J Clin Invest; 1989 Apr; 83(4):1313-8. PubMed ID: 2703533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute diabetes insipidus mediated by vasopressinase after placental abruption.
    Wallia A; Bizhanova A; Huang W; Goldsmith SL; Gossett DR; Kopp P
    J Clin Endocrinol Metab; 2013 Mar; 98(3):881-6. PubMed ID: 23393172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy.
    Lindheimer MD; Davison JM
    Eur J Endocrinol; 1995 Feb; 132(2):133-43. PubMed ID: 7858729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes insipidus in pregnancy.
    Dürr JA
    Am J Kidney Dis; 1987 Apr; 9(4):276-83. PubMed ID: 3554998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma vasopressin concentrations and serum vasopressinase activity in pregnant and nonpregnant women.
    Viinamäki O; Erkkola R; Kanto J
    Biol Res Pregnancy Perinatol; 1986; 7(1):17-9. PubMed ID: 3955123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of transient cranial diabetes insipidus during pregnancy.
    Williams DJ; Metcalfe KA; Skingle L; Stock AI; Beedham T; Monson JP
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):595-600. PubMed ID: 8334746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of AVP release by drinking despite hypertonicity during and after gestation.
    Davison JM; Shiells EA; Philips PR; Lindheimer MD
    Am J Physiol; 1988 Apr; 254(4 Pt 2):F588-92. PubMed ID: 3354688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance and urinary excretion of vasopressin in conscious dogs.
    Sondeen JL; Claybaugh JR
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R291-8. PubMed ID: 2916692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy.
    Davison JM; Gilmore EA; Dürr J; Robertson GL; Lindheimer MD
    Am J Physiol; 1984 Jan; 246(1 Pt 2):F105-9. PubMed ID: 6696073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume homeostasis and osmoregulation in human pregnancy.
    Davison JM; Lindheimer MD
    Baillieres Clin Endocrinol Metab; 1989 Aug; 3(2):451-72. PubMed ID: 2698144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmotic and volume control of vasopressin release in pregnancy.
    Lindheimer MD; Barron WM; Davison JM
    Am J Kidney Dis; 1991 Feb; 17(2):105-11. PubMed ID: 1992649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of biological activity of arginine vasopressin during its degradation by vasopressinase from pregnancy serum.
    Gordge MP; Williams DJ; Huggett NJ; Payne NN; Neild GH
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):51-8. PubMed ID: 7889632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Vasopressinase and Platelet Responses to Arginine Vasopressin in Normal Pregnancy, Pregnancy-induced Hypertension and Pre-eclampsia.
    Gordge MP; Robson SC; Williams DJ; Payne NN; Neild GH
    Platelets; 1994; 5(2):90-5. PubMed ID: 21043609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human pregnancy on metabolic clearance rate of oxytocin.
    Thornton S; Davison JM; Baylis PH
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R21-4. PubMed ID: 2375427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the renal concentration capacity following intravenous administration of dDAVP in healthy humans.
    Faerch M; Schroeder MK; Mahler BT; Christensen JH; Kamperis K; Rittig S
    Scand J Clin Lab Invest; 2018; 78(1-2):114-119. PubMed ID: 29361858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.